Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma
Pulmonary aspergillomas usually occur in pre-existing lung cavities exhibiting local immunodeficiency. As pulmonary aspergillomas only partially touch the walls of the cavities containing them, they rarely come into contact with the bloodstream, which makes it difficult for antifungal agents to reac...
Main Authors: | Takayuki Takeda, Hideki Itano, Ryouhei Kakehashi, Shinichi Fukita, Masahiko Saitoh, Sorou Takeda |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007114000057 |
Similar Items
-
Liposomal amphotericin B and leishmaniasis: Dose and response
by: Shyam Sundar, et al.
Published: (2010-01-01) -
Methods for particle size reduction of liposomal amphotericin B
by: Tuan Quang Nguyen, et al.
Published: (2018-03-01) -
Aspergilloma in sarcoidosis
by: Hede Jagruti, et al.
Published: (2009-01-01) -
Endobronchial amphotericin B to treat hemoptysis in an inoperable patient with aspergillosis
by: Mário Pinto, et al.
Published: (2024-03-01) -
Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations
by: Frédéric Frézard, et al.
Published: (2022-12-01)